Half-Year 2022 Financial Performance

Landmark investment in Fill & Finish to complete the value chain Delivering end-to-end solutions for our customers - ~CHF 500 million investment to build large-scale, commercial drug product fill and finish facility Fulfills strategic commitment to establish a commercial fill and finish offering Investment completes Lonza's integrated end-to-end customer offering Project expected to be completed in 2026 Image by PharmaPlan Agreement signed on June 30, 2022 Lonza Lonza

View entire presentation